SPY369.85+3.16 0.86%
DIA302.59+2.53 0.84%
IXIC12,464.23+87.05 0.70%

Bionano Genomics Q3 Sales $2.20M Beat $2.07M Estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $2.20 million which beat the analyst consensus estimate of $2.07 million by 6.09 percent. This is a 33.72 percent decrease over sales of $3.31 million the same

· 11/12/2020 16:04
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $2.20 million which beat the analyst consensus estimate of $2.07 million by 6.09 percent. This is a 33.72 percent decrease over sales of $3.31 million the same period last year.